Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / novocure off 15 on preliminary q4 results

NVCR - Novocure off 15% on preliminary Q4 results

NovoCure Limited

  • Novocure ( NASDAQ: NVCR ) is down ~15% in Monday afternoon trading after releasing preliminary Q4 2022 figures that came in below estimates.
  • The oncology focused pharma is expecting Q4 net revenue of $128.4 million, below the consensus in $128.69M.
  • As of December 31, 2022, there were 3,430 active patients on Optune, the Swiss pharma's Tumor Treating fields therapy for glioblastoma. Bloomberg had estimated 3,499.
  • Seeking Alpha contributor BioSci Capital Partners on Monday reiterated its strong buy rating fopr Novocure ( NVCR ) saying upcoming catalysts could lead to more upside .

For further details see:

Novocure off 15% on preliminary Q4 results
Stock Information
Company Name: NovoCure Limited
Stock Symbol: NVCR
Market: NASDAQ
Website: novocure.com
Menu
NVCR NVCR Quote NVCR Short NVCR News NVCR Articles NVCR Message Board
Get NVCR Alerts

News, Short Squeeze, Breakout and More Instantly...